Mar
13
2026
A rare disease patient advocate reflects on Zoya’s Law, early diagnosis, and why patients are a crucial stakeholder in research, policy, and national rare disease systems.

ERDERA interview with Bojana Mirosavljevic, rare disease patient advocate from Serbia and founder and president of Život/Life.

Bojana Mirosavljevic

News & Updates

You might also be interested in

State of the art rare disease country reports ERDERA 2025

State of the art 2025 rare disease country report: France

This 2025 country report outlines the policy, research, care and support landscape for rare diseases in France.
ERDERA trainings template (14)

Diagnostic Research Workstream Webinar Series – Session 3: The Data Reanalysis Approach

November 25 @ 1:00 pm - 2:00 pm
Intended for clinicians, clinical geneticists, researchers, data analysts and ERN members working in rare diseases
ERDERA trainings template (2)

Ethics & Artificial Intelligence in Scientific Research Webinar: Secure your spot!

December 4 @ 12:00 pm - 1:00 pm
Understanding the ethical concerns of AI in rare disease research and the principles of trustworthy AI
WODC EU 2026

ERDERA at World Orphan Drug Congress Europe 2026: exploring AI and advancing rare disease research

At the World Orphan Drug Congress Europe 2026 in Amsterdam, ERDERA contributed to discussions on artificial intelligence, clinical trials, emerging therapies and the future of rare disease research, including an interactive workshop on the responsible use of AI

ERDERA Search